ECOG performance status is an important risk factor for early mortality in metastatic castration-resistant prostate cancer (mCRPC). Patients with metastatic castration-resistant prostate cancer (mCRPC ...
Patients with ECOG performance status of 1 reported worse global health status, quality of life, and physical functioning than those with a status of 0. The RATIONALE-305 trial showed Tevimbra plus ...
Abbreviations: CCOP, Community Clinical Oncology Program; NCI, National Cancer Institute; NSCLC, non–small-cell lung cancer; QOL, quality of life; SD, standard deviation; VA, Veterans Affairs. On the ...
The era of value- and evidence-based care has come to oncology practice. Third-party payers approve treatment plans according to expert guidelines such as those of the National Comprehensive Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results